Ennature Bio Pharma posts Rs 5 cr PAT in Q2
Ennature Bio Pharma has achieved a profit after tax of Rs 4.89 crore in the second quarter of FY27, a notable turnaround from a loss of Rs 1.28 crore last year. The quarterly revenue surged to Rs 78.46 crore, compared to Rs 54.14 crore the previou...
By PTI |
Agencies
Ennature Bio Pharma on Saturday reported a profit after tax (PTI) of Rs 4.89 crore for September quarter FY27.
The company had incurred a loss of Rs 1.28 crore a year ago.
Revenue grew to Rs 78.46 crore during the quarter under review from Rs 54.14 crore a year ago, the company said in a statement.
The company's earnings before interest, taxes, depreciation, and amortisation (EBITDA) during the second quarter increased to Rs 10.34 crore from Rs 6.04 crore in Q2 FY26.
These are the company's first quarterly results following the demerger from India Glycols Ltd, the statement added.
The company had incurred a loss of Rs 1.28 crore a year ago.
Revenue grew to Rs 78.46 crore during the quarter under review from Rs 54.14 crore a year ago, the company said in a statement.
The company's earnings before interest, taxes, depreciation, and amortisation (EBITDA) during the second quarter increased to Rs 10.34 crore from Rs 6.04 crore in Q2 FY26.
These are the company's first quarterly results following the demerger from India Glycols Ltd, the statement added.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
